Recombinant anti-CD20 scFv-CD80-CD28-ζ non-replicating retroviral Construction.doc

Recombinant anti-CD20 scFv-CD80-CD28-ζ non-replicating retroviral Construction.doc

  1. 1、本文档共13页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Recombinant anti-CD20 scFv-CD80-CD28-ζ non-replicating retroviral Construction

 PAGE \* MERGEFORMAT 13 Recombinant anti-CD20 scFv/CD80/CD28/ζ non-replicating retroviral Construction [Abstract] Objective: To construct pLNCX/anti-CD20 scFv/CD80/CD28/ζ recombinant eukaryotic expression vector transfected cell line PA 317, packaging and preparation of recombinant non-replicating retrovirus. Methods: DNA recombinant technology to pBULLET on the CD28-ζ cDNA inserted into the anti-CD20 scFv/CD80 already included in the eukaryotic retroviral vector pLNCX plasmid transfected PA 317 cell lines by G418 selection, the supernatant was harvested Non-replicating retrovirus, the virus infected NIH 3T3 cell line, using PCR, flow cytometry of target genes in NIH 3T3 cells, determine the virus titer. Results: After digestion and sequencing confirmed the successful construction of pLNCX/anti-CD20scFv/CD80/CD28/ζ ; using RT-PCR from virus-infected NIH 3T3 cells was amplified by the size of a target gene with the same DNA fragment; flow cytometry showed that the gene can be expressed in NIH 3T3 cells, the target protein. Conclusion: The successfully constructed and expressed a high titer of anti-CD20 scFv/CD80/CD28/ζ non-replicating retrovirus, and NIH 3T3 cells in expression of the target protein. [Keywords:] Single-chain antibody PA 317 retrovirus gene expression in NIH 3T3 cells, cells Abstract: Objective: To construct recombinant eukaryotic expression vectors of pLNCX/anti- CD20scFv/CD80/CD28/ζ , transfect into PA 317 cells and package recombinant retroviruses. Methods: CD28-ζ cDNA were amplified from plasmids pBULLET and inserted into pLNCX vectors that contained anti-CD20 scFv/CD80 gene. The recombinant plasmids were transfected into PA 317 cells and resistant clones were obtained by G418 selection. Retroviruses were harvested from culture medium of PA 317 cells. Then NIH 3T3 were transfected with retroviruses. After G418 selection, objective gene expression was determined with PCR and FACS. Results: The recombinant eukaryotic vector was constructed

您可能关注的文档

文档评论(0)

hhuiws1482 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档